|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
De Souza Nunes LS, De Oliveira RV, Holgado
LA, Nary Filho H, Ribeiro DA and Matsumoto MA: Use of bovine
hydroxyapatite with or without biomembrane in sinus lift in
rabbits: histopathologic analysis and immune expression of core
binding factor 1 and vascular endothelium growth factor. J Oral
Maxillofac Surg. 69:1064–1069. 2011.
|
|
3
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
5
|
Chung TK, Cheung TH, Huen NY, Wong KW, Lo
KW, Yim SF, Siu NS, Wong YM, Tsang PT, Pang MW, Yu MY, To KF, Mok
SC, Wang VW, Li C, Cheung AY, Doran G, Birrer MJ, Smith DI and Wong
YF: Dysregulated microRNAs and their predicted targets associated
with endometrioid endometrial adenocarcinoma in Hong Kong women.
Int J Cancer. 124:1358–1365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu W, Lin Z, Zhuang Z and Liang X:
Expression profile of mammalian microRNAs in endometrioid
adenocarcinoma. Eur J Cancer Prev. 18:50–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Creasman W: Revised FIGO staging for
carcinoma of the endometrium. Int J Gynaecol Obstet. 105:1092009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ,
Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG and Bae DS: Altered
microRNA expression in cervical carcinomas. Clin Cancer Res.
14:2535–2542. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang F, Liu T, He Y, Yan Q, Chen X, Wang
H and Wan X: MiR-125b promotes proliferation and migration of type
II endometrial carcinoma cells through targeting TP53INP1 tumor
suppressor in vitro and in vivo. BMC Cancer. 11:4252011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu J, Ryan DG, Getsios S,
Oliveira-Fernandes M, Fatima A and Lavker RM: microRNA-184
antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Pro
Natl Acad Sci USA. 105:19300–19305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang J, Lee EJ, Gusev Y and Schmittgen
TD: Real-time expression profiling of microRNA precursors in human
cancer cell lines. Nucleic Acids Res. 33:5394–5403. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F,
Gomella LG, Croce CM and Baffa R: Micro-RNA profiling in kidney and
bladder cancers. Urol Oncol. 25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mouillet JF, Chu T, Nelson DM, Mishima T
and Sadovsky Y: MiR-205 silences MED1 in hypoxic primary human
trophoblasts. FASEB J. 24:2030–2039. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gandellini P, Folini M, Longoni N, Pennati
M, Binda M, Colecchia M, Salvioni R, Supino R, Moretti R, Limonta
P, Valdagni R, Daidone MG and Zaffaroni N: miR-205 exerts
tumor-suppressive functions in human prostate through
down-regulation of protein kinase Cepsilon. Cancer Res.
69:2287–2295. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tiraby C, Hazen BC, Gantner ML and Kralli
A: Estrogen-related receptor gamma promotes
mesenchymal-to-epithelial transition and suppresses breast tumor
growth. Cancer Res. 71:2518–2528. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu S, Wang X, Ng CF, Chen S and Chan FL:
ERRγ suppresses cell proliferation and tumor growth of
androgen-sensitive and androgen-insensitive prostate cancer cells
and its implication as a therapeutic target for prostate cancer.
Cancer Res. 67:4904–4914. 2007.
|
